Cite
HARVARD Citation
Cheng, H. et al. (2022). Clinical outcomes and metastatic behavior between de novo versus recurrent HER2-positive metastatic breast cancer: A 17-year single-institution cohort study at Taipei Veterans General Hospital. Journal of the Chinese Medical Association. 85 (1), pp. 88-94. [Online].